Clinical Chemistry, Malmö
1031 – 1040 of 1294
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2001
-
Mark
Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C
(
- Contribution to journal › Article
-
Mark
A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes
(
- Contribution to journal › Article
-
Mark
Localization of a hydrophobic binding site for anticoagulant protein S on the beta -chain of complement regulator C4b-binding protein
(
- Contribution to journal › Article
-
Mark
Islet autoantibodies in the prediction of diabetes in school children
(
- Contribution to journal › Article
-
Mark
Alpha-1-antitrypsin is present in the specific granules of human eosinophilic granulocytes
(
- Contribution to journal › Article
-
Mark
The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease
(
- Contribution to journal › Article
-
Mark
Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients
(
- Contribution to journal › Article
-
Mark
Tumor volume is a valid surrogate endpoint for defining clinically significant prostate cancers
(
- Contribution to journal › Article
-
Mark
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
(
- Contribution to journal › Article
-
Mark
Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer
(
- Contribution to journal › Article